ESPR Net Receivables

Esperion Therapeutics Inc · Net Receivables

ESPR logo

ESPR Net Receivables

Latest reported$132.35M
ESPR Quarterly Net Receivables ($0.00 → $132.35M)
High-resolution chart · PNG

ESPR net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
132,352,000
140,190,000
118,980,000
107,746,000
81,294,000
80,142,000
67,824,000
60,360,000
54,612,000
48,494,000
42,623,000
40,799,000
36,415,000
33,729,000
31,489,000
27,844,000
25,116,000
22,934,000
21,710,000
21,854,000
17,255,000
12,388,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.